A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Eltrekibart in Adult Participants with Moderate to Severe Hidradenitis Suppurativa
Clinical Trial Grant
Administered By
Dermatology
Awarded By
Lilly USA, LLC
Start Date
June 6, 2024
End Date
March 1, 2028
Administered By
Dermatology
Awarded By
Lilly USA, LLC
Start Date
June 6, 2024
End Date
March 1, 2028